What is Trial Runners?
Founded in 2006 and headquartered in Dickinson, North Dakota, Trial Runners operates as a critical partner in the drug development lifecycle. The organization provides comprehensive clinical management, data management, biostatistics, and quality assurance services specifically tailored to the complexities of ophthalmological research. By maintaining a narrow focus on eye-related clinical trials, the company has established itself as a high-authority entity within the niche CRO landscape, effectively bridging the gap between complex clinical data and regulatory compliance for its enterprise-level clients.
How much funding has Trial Runners raised?
Trial Runners has raised a total of $1.1M across 2 funding rounds:
Debt
$350K
Debt
$704K
Debt (2020): $350K with participation from PPP
Debt (2021): $704K led by PPP
Key Investors in Trial Runners
PPP
Public-Private Partnership
Undisclosed Investors
Undisclosed Investors
What's next for Trial Runners?
The infusion of capital, characterized as a major strategic investment, positions Trial Runners to scale its operational capacity and enhance its technological stack for data management. As the firm moves beyond its initial growth phases, the focus will likely shift toward increasing its global footprint and integrating advanced biostatistical modeling to accelerate trial timelines. This financial momentum suggests a long-term commitment to maintaining its competitive edge in the ophthalmology sector, ensuring that the company remains a preferred partner for biotech firms navigating the rigorous demands of clinical development and regulatory approval processes.
See full Trial Runners company page
